Role for neonatal D-serine signaling: prevention of physiological and behavioral deficits in adult Pick1 knockout mice

NMDA glutamate receptors have key roles in brain development, function and dysfunction. Regulatory roles of D-serine in NMDA receptor-mediated synaptic plasticity have been reported. Nonetheless, it is unclear whether and how neonatal deficits in NMDA-receptor-mediated neurotransmission affect adult...

Full description

Saved in:
Bibliographic Details
Published inMolecular psychiatry Vol. 21; no. 3; pp. 386 - 393
Main Authors Nomura, J, Jaaro-Peled, H, Lewis, E, Nuñez-Abades, P, Huppe-Gourgues, F, Cash-Padgett, T, Emiliani, F, Kondo, M A, Furuya, A, Landek-Salgado, M A, Ayhan, Y, Kamiya, A, Takumi, T, Huganir, R, Pletnikov, M, O'Donnell, P, Sawa, A
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.03.2016
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:NMDA glutamate receptors have key roles in brain development, function and dysfunction. Regulatory roles of D-serine in NMDA receptor-mediated synaptic plasticity have been reported. Nonetheless, it is unclear whether and how neonatal deficits in NMDA-receptor-mediated neurotransmission affect adult brain functions and behavior. Likewise, the role of D-serine during development remains elusive. Here we report behavioral and electrophysiological deficits associated with the frontal cortex in Pick1 knockout mice, which show D-serine deficits in a neonatal- and forebrain-specific manner. The pathological manifestations observed in adult Pick1 mice are rescued by transient neonatal supplementation of D-serine, but not by a similar treatment in adulthood. These results indicate a role for D-serine in neurodevelopment and provide novel insights on how we interpret data of psychiatric genetics, indicating the involvement of genes associated with D-serine synthesis and degradation, as well as how we consider animal models with neonatal application of NMDA receptor antagonists.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current affiliation: RIKEN Brain Science Institute and Hiroshima University
Current affiliation: Psychiatry & Behavioral Disorders, Neuroscience Research Unit, Pfizer
Current affiliation: Departamento de Fisiologia, Universidad de Sevilla, Spain
ISSN:1359-4184
1476-5578
DOI:10.1038/mp.2015.61